Clinical impact of nutrition and inflammation assessment tools in pancreatic cancer treatment
T Aoyama, Y Maezawa, I Hashimoto, Y Rino… - Anticancer …, 2023 - ar.iiarjournals.org
Perioperative adjuvant treatment and complete resection is the standard treatment for
resectable pancreatic cancer and systemic chemotherapy is standard treatment for …
resectable pancreatic cancer and systemic chemotherapy is standard treatment for …
A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
I Garajová, M Peroni, F Gelsomino, F Leonardi - Current Oncology, 2023 - mdpi.com
Pancreatic cancer (PDAC) is one of the most aggressive solid tumors and is showing
increasing incidence. The aim of our review is to provide practical help for all clinical …
increasing incidence. The aim of our review is to provide practical help for all clinical …
Outcomes of pancreatic cancer with liver oligometastasis
T Takeda, T Sasaki, T Okamoto… - Journal of Hepato …, 2023 - Wiley Online Library
Background Liver oligometastatic pancreatic cancer (PC) may have favorable outcomes.
This study aims to evaluate outcomes and factors associated with overall survival (OS) of …
This study aims to evaluate outcomes and factors associated with overall survival (OS) of …
[HTML][HTML] Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial …
Background The efficacy of modified FOLFIRINOX (mFOLFIRINOX) as a second-line
chemotherapy treatment for metastatic pancreatic adenocarcinoma (mPAC), remains …
chemotherapy treatment for metastatic pancreatic adenocarcinoma (mPAC), remains …
[HTML][HTML] Prognostic and clinical significance of modified Glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients
D Wu, X Wang, G Shi, H Sun, G Ge - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
In this study, we evaluated the association of modified Glasgow Prognostic Score (mGPS)
with prognosis in pancreatic cancer (PC) by performing a meta-analysis. Potentially eligible …
with prognosis in pancreatic cancer (PC) by performing a meta-analysis. Potentially eligible …
Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome
A combination of chemotherapy with immunotherapy has been proposed to have better
clinical outcomes in Pancreatic Ductal Adenocarcinoma (PDAC). On the other hand …
clinical outcomes in Pancreatic Ductal Adenocarcinoma (PDAC). On the other hand …
[HTML][HTML] Real-world evidence on first-and second-line palliative chemotherapy in advanced pancreatic cancer
H Blomstrand, A Batra, WY Cheung… - World Journal of …, 2021 - ncbi.nlm.nih.gov
In spite of recent diagnostic and therapeutic advances, the prognosis of pancreatic ductal
adenocarcinoma (PDAC) remains very poor. As most patients are not amenable to curative …
adenocarcinoma (PDAC) remains very poor. As most patients are not amenable to curative …
Advanced pancreatic ductal adenocarcinoma: moving forward
C Franck, C Müller, R Rosania, RS Croner, M Pech… - Cancers, 2020 - mdpi.com
Globally, the death rate of pancreatic ductal adenocarcinoma (PDAC) has doubled over 30
years and is likely to further increase, making PDAC a leading cause of cancer-related death …
years and is likely to further increase, making PDAC a leading cause of cancer-related death …
Systemic therapy of metastatic pancreatic adenocarcinoma: Current status, challenges, and opportunities
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a common type of cancer
originating from the pancreatic glands and is characterized by a rapidly progressive course …
originating from the pancreatic glands and is characterized by a rapidly progressive course …
[HTML][HTML] Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy
X Wei, P Li, H Zhou, X Hu, D Liu, J Wu… - Journal of Photochemistry …, 2021 - Elsevier
Gemcitabine (GEM) and its derivatives of deoxycytosine is a promising anticancer candidate
which is effective for the treatment of various cancers including lung cancer via cascade …
which is effective for the treatment of various cancers including lung cancer via cascade …